Nalaganje...
Predictive biomarkers for tumor immune checkpoint blockade
The development of immune checkpoint inhibitors represented by PD-1 and PD-L1 has provided new hope for the treatment of advanced cancer patients. However, there are no effective predictive biomarkers, which have caused many limitations to the clinical application of immune checkpoint inhibitors. Th...
Shranjeno v:
| izdano v: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6190817/ https://ncbi.nlm.nih.gov/pubmed/30349382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S179680 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|